Thus, these results indicate that the administration of E. callanderi live bacteria and EcCFS exhibited anti-CRC activity in vivo, leading to the reduction of IL-6 levels in serum and tumor apoptosis. The gene discussed is IL6; the disease is colorectal carcinoma.